OGC
CTSO icon

One68 Global Capital’s Cytosorbents Corp CTSO Stock Holding History

One68 Global Capital’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-39,241
Closed -$151K – 21
2019
Q4 		$151K Buy
+39,241
New +$171K 0.33% 63

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

One68 Global Capital's CTSO Position: Q1 2020 in Review

One68 Global Capital sold out of Cytosorbents Corp (CTSO) in Q1 2020, closing a stake of 39,241 shares — an estimated $151K sold.

One68 Global Capital first reported a position in CTSO in Q4 2019 and held it in 1 quarter. The position peaked at $151K in Q4 2019. 82 funds tracked by Wall St. Rank hold CTSO as of Q1 2020.

  • One68 Global Capital reported no remaining Cytosorbents Corp position as of Q1 2020 after selling out during the quarter.
  • One68 Global Capital sold 39,241 Cytosorbents Corp shares in Q1 2020, an estimated $151K.
  • One68 Global Capital first reported a position in Cytosorbents Corp in Q4 2019 and held it in 1 quarter.
  • One68 Global Capital's Cytosorbents Corp position peaked at $151K in Q4 2019.
  • 82 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2020.

Based on One68 Global Capital's 13F filing for Q1 2020, filed 15 May 2020.